Retatrutide
TRIUMPH-1
Eli Lilly · Phase 3 · Completed · Enrollment 2335
| Arm | Nausea | Vomiting | Diarrhea | Discontinuation | Deaths |
|---|---|---|---|---|---|
| retatrutide 4 mg | n/r | n/r | n/r | n/r | n/r |
| retatrutide 9 mg | n/r | n/r | n/r | n/r | n/r |
| retatrutide 12 mg | n/r | n/r | n/r | n/r | n/r |
| Placebo | n/r | n/r | n/r | n/r | n/r |
A count stays a count. This page does not turn a count into a percent.